Their own payment-practices filing · gov.uk
Lonza Biologics PLC pays suppliers in 70 days on average — inside its 90-day stated terms
Their H1 2026 filing puts the average 20 days inside their stated 90-day term.
- Their stated terms
- 90 days
- Paid outside agreed terms
- 74% of invoices
- Paid after 61+ days
- 58%
- Reporting period
- 1 Jan 2026 – 30 Jun 2026
- Source
- their gov.uk filing, filed 16 Jul 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H1 2026 filing
Paid 20 days inside the 90-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 15 reports
45 → 70 days — slowing down
The read · computed from their figures
Lonza Biologics PLC's H1 2026 filing puts their average at 70 days against stated terms of 90 days; 74% of invoices were paid outside agreed terms and 58% took 61 days or longer. Filed 16 Jul 2026.
The direction is slower: from 45 days in H2 2023 to 70 now — 25 days slower across their last 6 reports.
On the latest reported averages: Slower than 95% of the 115 large companies reporting in other services.
That is 15 statutory periods on record (earliest H1 2019) — a historical record, not a promise for a new invoice.
In their own words · from the filing
Standard payment terms
There are no standard published payment terms for Lonza Biologics PLC, but most contracts are agreed with terms that allow for payment within 31-60 days
Dispute resolution
Invoices which are incorrectly issued, or are issued in opposition to the previous contract agreements or arrangements are rejected by email to the vendor's correspondence address held within Lonza's systems; with accompanying instructions on what should be corrected for the invoice to be accepted. Lonza Biologics also operates a PO policy, where invoices without a Lonza PO are rejected unless specifically agreed in the contract with the vendor.
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H1 2026 | 70 | 74% | 58% | 16 Jul 2026 |
| H2 2025 | 58 | 18% | 18% | 27 Jan 2026 |
| H1 2025 | 59 | 13% | 13% | 30 Jul 2025 |
| H2 2024 | 56 | 12% | 10% | 28 Jan 2025 |
| H1 2024 | 64 | 17% | 13% | 23 Jul 2024 |
| H2 2023 | 45 | 14% | 4% | 9 Jan 2024 |
| H1 2023 | 60 | 25% | 17% | 1 Aug 2023 |
| H2 2022 | 70 | 33% | 32% | 31 Jan 2023 |
| H1 2022 | 57 | 4% | 29% | 1 Aug 2022 |
| H2 2021 | 56 | 5% | 26% | 31 Jan 2022 |
| H1 2021 | 51 | 4% | 27% | 30 Jul 2021 |
| H2 2020 | 55 | 6% | 27% | 21 Feb 2021 |
| H1 2020 | 59 | 25% | 28% | 31 Jul 2020 |
| H2 2019 | 48 | 31% | 16% | 4 Feb 2020 |
| H1 2019 | 53 | 31% | 16% | 3 Sept 2019 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- Public Limited Company
- Incorporated
- 25 Aug 1992
- Registered office
- 228 BATH ROAD, BERKSHIRE, SL1 4DX
Quick answers · Lonza Biologics PLC
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Lonza Biologics PLC (free)
Their next payment report is due ≈ 26 Jan 2027. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in other services
Landmark Space Limited · Magnox Limited · KBR (Aspire Services) Limited · Manheim Limited · KBR (Aspire Construction) Limited · Marmon Group Limited(THE)
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-02742471 · latest period to 30 Jun 2026
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.